Wine phenolics: Chemistry, biosynthesis and effects on health

Wine: Types, Production and Health

Volumn , Issue , 2012, Pages 387-427

  Kelebek, Hasim ^a   Selli, Serkan ^b  

^a University of Adiyaman   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881027447     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (90)

1. Kelebek, H.; Canbas, A.; Selli, S.; Saucier, C.; Jourdes, M.; Y. Glories, Y. Influence of different maceration times on the anthocyanin composition of wines made from Vitis vinifera L. cvs. Bogazkere and Okuzgozu. J. Food Eng. 2006, 77, 1012-1017.
2. Walzem, R.L. Wine and healty: state of proofs and research needs. Inflam-mopha-rmacology. 2008, 16, 265-271.
3. Lucia, S.P. A History of Wine as Therapy., 1963. Lippincott, Philadelphia, PA.
4. Rodrigo, R.; Miranda, A.; Vergara, L. Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin. Chim. Acta 2011, 412, 410-424.-.
5. Renaud, S.; De Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet, 1992, 339, 1523-1526.
6. de Lange, D.W. (2007). From red wine to polyphenols and back: A journey through the history of the French Paradox. Throm. Res., 2007, 119, 403-406.
7. de Leiris, J.; Boucher, F.; Ducimetière, P.; Holdsworth, M. The French Paradox: Fact or Fiction? Dialog. Cardio. Med., 2008, 13, 181-208.
8. Stanley, L.L.; Mazier, M.J.P. Potential explanation fort he french paradox. Nutr. Res., 1999, 19, 3-15.
9. Keys, A.; Menotti, A.; Karvonen, M.J.; Aravanis, C.; Blackburn, H.; Buzina, R. The diet and 15-year death rate in the seven countries study. Am. J. Epidemiol. 1986, 124, 903-915.
10. Natalya Bilenko, M.D.; Drora Fraser, M.P.H.; Hillel Vardi, M.A.B.; Shai, I.; Shahar, D.R. Mediterranean diet and cardiovascular diseases in an Israeli population. Prevent Med., 2005, 40, 299-305.
11. Panagiotakos, D.B.; Christos Pitsavos, C.; Stefanadis, C. Dietary patterns: A Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr. Metabol. Cardio. Dis., 2006, 16, 559-568.
12. Estruch, R. Wine and cardiovascular disease. Food Res. Intern., 2000, 33, 219-226.
13. German, J.B.; Walzem, R.L. The health benefits of wine. Annu. Rev. Nutr. 2000, 20, 561-593.
14. Gronbaek, M.; Deis, A.; Sorensen, T.I.A.; Becker, U.; Borch-Johnsen, K.; Muller, C.; Schnorr, P.; Jensen, G. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. Br. Med. J., 1994, 308, 302-306.
15. Serafini, M.; Maiani, G.; Ferro-Luzzi, A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr., 1998, 128, 1003-1007.
16. Booyse, F.M.; Parks, D.A. Moderate wine and alcohol consumption: beneficial effects on cardiovascular disease. Thromb. Haemost., 2001, 86, 517-528.
17. Klatsky, A.L.; Friedman, G.D.; Armstrong, M.A.; Kipp, H. Wine, liquor, beer, and mortality. Am. J. Epidemiol., 2003, 158, 585-595.
18. Pace-Asciak, C.R.; Hahn, S.; Diamandis, E.P.; Soleas, G.; Goldberg, G.M. The red wine phenolics trans-reservatrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta, 1995, 235, 207-219.
19. Paschall, M.; Lipton, R.I. Wine preference and related health determinants ina U.S. national sample of young adults. Drug Alcohol Depend., 2005, 78, 339-344.
20. Truelsen, T.; Gronbaek, M.; Schnohr, P.; Boysen, G. Intake of beer, wine, and spirits and risk of stroke. Stroke, 1998, 29, 2467-2472.
21. Charters, S. Wine and society: the social and cultural context of a drink. Elsevier Ltd. Oxford, 2006, UK.
22. Perreira, K.M.; Sloan, F.A. Excess alcohol consumption and health outcomes: a 6-year follow-up of men over age 50 from the health and retirement study. Addiction, 2002, 97, 301-310.
23. U.S. Department of Health and Human Services, U.S. Department of Agriculture., 2000. Nutrition and your health: dietary guidelines for Americans, 5th ed. Home and Garden Bulletin No. 232. U.S. Department of Agriculture, Washington, DC.
24. Lorimier, A.A. Alcohol, wine and health. Am J. Surg., 2000, 180, 357-361.
25. Dohadwala, M.M.; Vita, J.A. Grapes and cardiovascular disease. J. Nutr., 2009, 139, 1788-1793.
26. Dudley, J.I.; Lekli, I.; Mukherjee, S.; Das, M.; Bertelli, A.A.A.; Das, D.K. Does white wine qualify for French Paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol. J. Agric. Food Chem., 2008, 56, 9362-9373.
27. Lippi, G.; Franchini, M.; Guidi, G.C. Red wine and cardiovascular health: the RFrench paradoxr revisited. Int. J. Wine Res., 2010, 2, 1-7.
28. Pellegrini, N., Simonetti P., Brusamolino, A, Bottasso, B., Pareti, F.I. Composition of platelet phospholipids after moderate consumption of red wine in healthy volunteers. Eur. J. Clin. Nutr., 1996, 50, 535-544.
29. Di Castelnuovo, A.; Costanzo, S.; Donati, M.B.; Iacoviello, L.; de Gaetano, G. Prevention of cardiovascular risk for moderate alcohol consumption: epidemiologic evidence and plausible mechanisms. Intern. Emerg. Med., 2010, 5, 291-297.
30. Collins M.A.; Neafsey, E.J.; Mukamal, K.J.; Gray, M. O.; Parks, D. A.; Das, D. K.; Korthuis, R. J. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin. Exp. Res. 33, 206-219.
31. Rimm, E.B.; Williams, P.; Fosher, K.; Criqui, M.; Stampfer, M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Bri. Med. J., 1999, 319, 1523-1528.
32. St Leger, A.S.; Cochrane, A.L.; Moore, F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet, 1979, 12, 1017-1720.
33. Munoz-Munoz, J.L.; García-Molina, F.; Molina-Alarcón, M.; Tudela, J.; García-Cánovas, F.; Rodríguez-López J.N. (2008). Kinetic characterization of the enzymatic and chemical oxidation of the catechins in green tea. J. Agric. Food Chem., 2008, 56, 9215-9224.
34. Gronbaek, M.; Deis A.; Sorensen, T.I.; Becker, U.; Schnohr, P.; Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Brit. Med. J. 1995, 310, 1165-9.
35. Dernek, S.; Ikizler, M.; Erkasap, N.; Ergun, B.; Koken, T.; Yilmaz, K.; Sevin, B.; Kaygisiz, Z.; Kural, T. Cardioprotection with resveratrol pretreatment: improved beneficial effects over Standard treatment in rat hearts after global ischemia Scan. Cardio. J. 2004, 38, 245-254.
36. Hung, L. M.; Chen, J. K.; Huang, S. S.; Lee, R. S.; Su, M. J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes Cardio. Res., 2000, 47, 549-555.
37. King, R. E.; Bomser, J. A.; Min, D. B. Bioactivity of resveratrol. Compr. Rev. Food Sci. Food Safety, 2006, 5, 65-70.
38. Pal, S.; Ho, N.; Santos, C.; Dubois, P.; Mamo, J.; Croft, K.; Allister, E. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells, J. Nutr., 2003, 133, 700-706.
39. Frankel, E.N.; Waterhouse, A.L.; Kinsella, J.E. Inhibition of oxidation of human low density lipoproteins by phenolic substances in red wine. Lancet, 1993, 341, 454-457.
40. Yla-Herttuala, S.; Palinski, W.; Rosenfeld, M.E.; Parthasarathy, S.; Carew, T.E.; Butler, S.; Witztum, J.L.; Steinberg, D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesion of rabbit and man. J. Clin. Invest., 1989, 84, 1086-1095.
41. de Rijke, Y.B.; Demacker, P.N.M.; Assen, N.A.; Sloots, L.M.; Katan, M.B.; Stalenhoef, A.F.H. Red wine consumption and oxidation of low-density lipoproteins. Lancet, 1995, 345, 325-326.
42. Kondo, K.; Matsumoto, A.; Kurata, H.; Tanahashi H.; Koda, H.; Amachi, T.; Itakura, H. Inhibition of oxidation of low-Denise lipoprotein with red wine. Lancet, 1994, 344, 1152-1158.
43. Maxwell, S.; Cruickshank, A.; Thorpe G. Red wine and antioxidant activity in serum. Lancet, 1994, 344, 193-194.
44. Whitehead, T.P.; Robinson, D.; Allaway, S.; Syms, J.; Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin. Chem., 1995, 41, 32-35.
45. Fuhrman, B.; Lavy, A.; Aviram, M. (1995) Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr., 1995, 61, 549-554.
46. Mackness, M.I.; Abbott, C.; Arrol, S.; Derrington P.N. The role of high density lipoprotein and lipid soluble antioxidant vitamins in inhibiting low density lipoprotein oxidation. Biochem J., 1993, 294, 829-834.
47. Toufektsian, M.C.; de Lorgeril, M.; Nagy, N.; et al. (2008). Protection against myocardial infarction after long-term chronic dietary intake of plantderived anthocyanins protects the rat heart against regional ischemia-reperfusion injury. J. Nutr. 138, 747-752.
48. Cui, J.; Tosaki, A.; Cordis G.A.; Bertelli, A.A.E.; Bertelli, A.; Maulik, N.; Das, D.K. Cardioprotective abilities of white wine. Ann. N. Y. Acad. Sci., 2002, 957, 308-316.
49. Satué-Garcia, M. T.; Andrés-Lacueva, C.; Lamuela-Raventós, R. M.; Frankel, E. N. Spanish sparkling wines (Cavas) as inhibitors of in vitro human lowdensity lipoprotein oxidation. J. Agric. Food Chem. 1999, 47, 2198-2202.
50. Stefenon C.A.; Colombo, M.; Bonesi, C.M.; Marzarotto, V.; Vanderlinde, R.; Salvador, M.; Henriques, J.A.P. Antioxidant activity of sparkling wines produced by Champenoise and Charmat methods. Food Chem., 2010, 119, 12-18.
51. Thirunavukkarasu, M.; Penumathsa, S. V.; Samuel, S. M.; Kita, Y. A.; Zhan, L. J.; Bertelli, A. A. E.; Maulik, G.; Maulik, N. White wine induced cardioprotection against ischemia reperfusion injury is mediated by life extending Akt/FOXO3a/NF kappa B survival pathway. J. Agric. Food Chem., 2008, 56, 6733-6739.
52. Aziz, M.H., Kumar, R., Ahmad, N. (2003). Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (Review) Int J Oncol 23, 17-28.
53. Mukhtar H., Ahmad N. (1999). Cancer chemoprevention: future holds in multiple agents: contemporary issues in Toxicology. Toxicol Appl Pharmacol 158, 207-210.
54. Bradlow, H. L.; Telang, N. T.; Sepkovic, D. W.; Osborne, M. P. (1999). Phytochemicals as modulators of cancer risk. Adv. Exp. Med. Biol., 472, 207-221.
55. Gali, H. U.; Perchellet, E. M.; Klish, D. S.; Johnson, J. M.; Perchellet, J. P. Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 2-0-tetradecanoylphorbol-l3-acetate in vivo. Int. J. Cancer, 1992, 51, 425-432.
56. He, S.; Sun C.; Pan, Y. Red Wine Polyphenols for Cancer Prevention Int. J. Mol. Sci. 2008, 9, 842-853.
57. Soleas, G. J.; Diamandis, E. P.; Goldberg, D. M. Wine as a biological fluid: History, production, and role in disease prevention. J. Clin. Lab. Anal. 1997, 11, 287-313.
58. Clifford, A. J.; Ebeler, S. E.; Ebeler, J. D.; Bills, N. D.; Hinrichs, S. H.; Teissedre, P.-L.; Waterhouse, A. L. Delayed tumor onset in transgenic mice fed an amino acid based diet supplemented with red wine solids. Am. J. Clin. Nutr. 1996, 64, 748-756.
59. Moreno, A., Castro, M., Falque, E. Evolution of trans- and cis-resveratrol content in red grapes (Vitis vinifera L. cv Mencía, Albarello and Merenzao) during ripening, Eur. Food Res. Technol., 2008, 227, 667-674.
60. Moreno-Labanda, J.; Mallavia, R.; Perez-Fons, L.; Lizama, V.; Saura, D.; Micol, V. Determination of piceid and resveratrol in Spanish wines deriving from Monastrell (Vitis vinifera L.) grape variety. J Agric. Food Chem., 2004, 52, 5396-5403.
61. Lopez-Hernandez, J.; Paseiro-Losada, P.; Sanches-Silva, A.T.; Lage-Yusty, M.A. Study of the changes of trans-resveratrol caused by ultraviolet light and determination of trans- and cis-resveratrol in Spanish white wines. Eur. Food Res. Technol., 2007, 225, 789-796.
62. Jang, M., Cai, L., Udean,i G.O.; Slowing, K.V.; Thomas, C.F.; Beecher, C.W.W.; Fong H.H.S.; Farnsworth, N.R.; Kinghorn, A.D.; Mehta, R.G.; Moon, R.C.; Pezzuto, J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275, 218-220.
63. Lin, J.K.; Tsai, S.H. Chemoprevention of cancer and cardiovascular disease by resveratrol Proc. Natl. Sci. Counc. 1999, 23, 99-106.
64. Bianchini F.; Vainio, H. Wine and resveratrol: mechanisms of cancer prevention? Eur J Cancer Prev., 2003, 12, 417-425.
65. Delmas, D.; Lançon, A.; Colin, D.; Jannin, B.; Latruffe, N. Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer Current Drug Targets, 2006, 7, 423-442.
66. Gusman, J.; Malonne, H.; Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis, 2001, 22, 1111-1117.
67. Jang, M.; Pezzuto, J.M. Resveratrol blocks eicosanoid production and chemical-induced transformation: implications for cancer chemoprevention, Pharm. Biol., 1998, 36, 28-34.
68. Wolter, F.; Akoglu, B.; Clausnitzer, A.; Stein, J. Down-regulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J. Nutr., 2001, 131, 2197-2203.
69. Garcia-Alonso, J.; Ros, G.; Vidal-Guevara, M.L.; Periago, M.J. (2006). Acute intake of phenolic-rich juice improves antioxidant status in healthy subjects., Nutr. Res., 2006, 26, 330-339.
70. de Bruyne, T.; Pieters, L.; Witvrouw, M.; de Clercq, E.; Berghe, D.V.; Vlietinck, A.J. (1999). Biological evaluation of proanthocyanidin dimers and related polyphenols. J. Nat. Prod. 62, 954-958.
71. Xia, E.Q.; Deng, G.F.; Ya-Jun, G., Li, H.B. Biological Activities of Polyphenols from Grapes, Int. J. Mol. Sci., 2010, 11, 622-646.
72. Just, J.R.; Daeschel, M. A. Antimicrobial effects of wine on Escherichia coli O157:H7 and Salmonella typhimurium in a stomach model system. J Food Sci., 2003, 68, 285-290.
73. Boban, N.; Tonkic, M.; Budimir, D.; Modun, D.; Sutlovic, D.; Punda-Polic, V.; Boban M. Antimicrobial Effects of Wine: Separating the Role of Polyphenols, pH, Ethanol, and Other Wine Components. J. Food Sci., 2010, 75, 322-326.
74. Lamuela-Raventos, R.M.; de la Tarre-Boronat, M.C. Beneficial effects of white wines. Drugs Exp. Clin. Res. 1999, 25, 121-124.
75. Radovanovic, A.; Radovanovic, B.; Jovancicevic, B. Free radical scavenging and antibacterial activities of southern Serbian red wines. Food Chem., 2009, 117, 326-31.
76. Vaquero, M.J.R.; Alberto, M.R.; de Nadra M.C.M. Antibacterial effect of phenolic compounds from different wines. Food Cont., 2007, 18, 93-101.
77. Sugita-Konishi, Y.; Hara-Kudo, Y.; Iwamoto, T.; Kondo, K. (2001). Wine has activity against entero-pathogenic bacteria in vitro but not in vivo. Biosci., Biotechnol., Biochem., 2001, 65, 954-957.
78. Daroch, F.; Hoeneisen, M.; Gonzalez, C. L.; Kawaguchi, F.; Salgado, F.; Solar, H.; Garcia, A. In vitro antibacterial activity of Chilean red wines against Helicobacter pylori. Microbios, 2001, 104, 79-85.
79. Paulo, L.; Oleastro, M.; Gallardo, E.; Queiroz, J.A.; Domingues, F. (2011). Anti-Helicobacter pylori and urease inhibitory activities of resveratrol and red wine. Food Res. Intern., 2011, 44, 964-969.
80. Shan, B.; Cai, Y.Z.; Brooks, J.D.; Corke, H. Antibacterial properties of Polygonum cuspidatum roots and their major bioactive constituents. Food Chem., 2008, 109, 530-537.
81. Wang, W. B.; Lai, H. C.; Hsueh, P. R.; Chiou, R. Y. Y.; Lin, S. B.; Liaw, S. J. Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol. J. Med. Microbiol, 2006, 55, 1313-1321.
82. Chan, M.M.Y. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem. Pharmacol. 2002, 63, 99-104.
83. Chiang, L.C.; Chiang, W.; Liu M.C.; Lin C.C. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J. Antimicrob. Chemther. 2003, 52, 194-198.
84. Cushnie, T.P.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents, 2005, 26, 343-356.
85. Napoli, C.; Balestrieri, M.L.; Sica, V.; Lerman, L.O., Crimi, E., De Rosa, G.; Schiano, C.; Sevillo, L., D'Armiento, F.P. Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis. Heart Vessels, 2008, 23, 124-133.
86. Pace-Asciak, C.R., Rounova, O., Hahn, S.E., Diamandis, E.P., Goldberg, D.M. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta. 1996, 246, 163-182.
87. Drel, V.R.; Sybirna, N. Protective effects of red wine on diabetes associated oxidative/nitrative stress in streptozotocin-diabetic rats. Cell Biol. Int. 2010, 34, 1147-1153.
88. Bralley E.E.; Hargrove J.L.; Greenspan P.; Hartle D.K. Topical anti-inflammatory activities of Vitis rotundifolia (Muscadine Grape) extracts in the tetradecanoylphorbol acetate model of ear inflammation. J. Med. Food 2007, 10, 636-642.
89. Luchsinger, J.A.; Tang, M.X.; Siddiqui, M.; Shea, S.; Mayeux, R. Alcohol intake and risk of dementia. J. Am. Geriatr. Soc. 2004, 52, 540-546.
90. Balu, M.; Sangeetha, P.; Murali, G.; Panneerselvam, C. Modulatory role of grape seed extract on age-related oxidative DNA damage in central nervous system of rats. Brain Res. Bull. 2006, 68, 469-473.